Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trypsin mutants for structure-based drug design: expression, refolding and crystallisation.

Daniel Rauh1, Sabine Reyda, Gerhard Klebe

  • 1Institut für Pharmazeutische Chemie der Philipps-Universität Marburg, Germany.

Biological Chemistry
|November 20, 2002
PubMed
Summary

Researchers used bovine trypsin as a surrogate protein to design drugs targeting factor Xa, overcoming challenges in protein crystallization for novel drug discovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of Water in Protein-Ligand Binding: Decisive Factor, Annoying Feature, or Indispensable Control Element: In Any Case, a Major Challenge.

ChemMedChem·2026
Same author

Elimusertib enhances cytotoxic effects of conventional chemotherapy and sensitizes to radiation in preclinical Ewing sarcoma models.

Scientific reports·2026
Same author

Lipid Pocket Binders Impose Allosteric Changes of Protein Dynamics Around the Active Site of the Protein Kinase p38α.

Angewandte Chemie (International ed. in English)·2026
Same author

Lessons from Structural Biology for Understanding Drug Resistance in Gastrointestinal Stromal Tumors (GIST).

Journal of medicinal chemistry·2026
Same author

Thermodynamic Data Remain a Hot Tip for Decoding Binding Affinity and Water Impact on Protein-Ligand Complex Formation to Assist Lead Optimization.

Journal of medicinal chemistry·2026
Same author

Total Synthesis and Structural Revision of Keenamide A.

Journal of natural products·2026

Area of Science:

  • Biochemistry
  • Structural Biology
  • Drug Discovery

Background:

  • Novel drug development requires innovative techniques.
  • Serine proteinase structure determination aids computer-based drug design.
  • Lack of suitable crystals hinders drug design for many proteins.

Purpose of the Study:

  • To investigate the use of surrogate proteins for studying protein-ligand interactions.
  • To test the feasibility of using bovine trypsin as a scaffold to reconstruct the ligand binding site of factor Xa.
  • To develop a drug design by proxy strategy.

Main Methods:

  • Utilized bovine trypsin as a scaffold.
  • Reconstructed the ligand binding site of factor Xa.
  • Characterized engineered bovine trypsin via expression, folding, purification, crystallography, and kinetics.

Related Experiment Videos

Main Results:

  • Successfully created bovine trypsin forms with factor Xa phenotype.
  • Demonstrated the feasibility of using a surrogate protein scaffold.
  • Provided crystallographic and kinetic data for the engineered protein.

Conclusions:

  • Bovine trypsin serves as a viable scaffold for drug design by proxy.
  • This approach circumvents crystallization challenges for target proteins like factor Xa.
  • The methodology facilitates the development of novel therapeutics.